The Plasma Free Fraction of 25-hydroxyvitamin D is Not Strongly Associated with 25-hydroxyvitamin D Clearance in Kidney Disease Patients and Controls

Overview

Journal J Steroid Biochem Mol Biol

Specialties Biochemistry
Molecular Biology

Date 2022 Nov 21

PMID 36404469

Authors

Cora M Best

Kenneth E Thummel

Simon Hsu

Yvonne Lin

Leila R Zelnick

Bryan Kestenbaum

Mark M Kushnir

Ian H de Boer

Andrew N Hoofnagle

Affiliations

Soon will be listed here.

Abstract

Circulating 25-hydroxyvitamin D [25(OH)D] concentration is used to monitor vitamin D status. Plasma protein binding may influence the 25(OH)D dose-response to vitamin D treatment through a direct relationship between the plasma unbound ("free") fraction and clearance of 25(OH)D. We previously evaluated 25(OH)D clearance in relation to kidney function using intravenous administration of deuterium labeled 25(OH)D. In this follow up study, we determined the free fraction of 25(OH)D in plasma (i.e., percent free 25(OH)D) and the serum concentration and haplotype of vitamin D binding protein in these participants. We hypothesized that the percent free 25(OH)D would be positively associated with 25(OH)D clearance and would mediate associations between clearance and vitamin D binding protein (GC) haplotypes. Participants were mean (SD) age 64 (10) years and included 42 individuals with normal kidney function (controls), 24 individuals with chronic kidney disease, and 19 individuals with kidney failure on hemodialysis. Free plasma 25(OH)D and 25(OH)D concentrations were quantified with a new liquid chromatography-tandem mass spectrometry (LC-MS/MS) method. Because there is no reference measurement procedure for free 25(OH)D, we compared the new method with a widely-used predictive equation and a commercial immunoassay. The percent free 25(OH)D determined by predictive equation was weakly associated with 25(OH)D clearance (R = 0.27; P = 0.01). However, this association was absent when percent free 25(OH)D was determined using LC-MS/MS-measured free and total 25(OH)D concentrations. Method comparison uncovered a negative bias in immunoassay-measured free 25(OH)D concentrations among participants with kidney failure, so immunoassay results were not used to evaluate the association between percent free 25(OH)D and clearance. GC2 haplotype carriage was associated with 25(OH)D clearance. Among individuals with 2 relative to no GC2 alleles, clearance was 87 (95% CI: 15-158) mL/d greater. However, in contrast with the literature, GC2 carriage was not significantly related to DBP concentration or the percent free 25(OH)D (either predicted or measured). In conclusion, the free fraction of 25(OH)D is not strongly associated with 25(OH)D clearance but may explain small differences in clearance according to GC haplotype.

Citing Articles

The Vitamin D Metabolite Ratio (VMR) is a Biomarker of Vitamin D Status That is Not Affected by Acute Changes in Vitamin D Binding Protein.

Dugar A, Hoofnagle A, Sanchez A, Ward D, Corey-Bloom J, Cheng J Clin Chem. 2023; 69(7):718-723.

PMID: 37220642 PMC: 10320009. DOI: 10.1093/clinchem/hvad050.

References

Enlund-Cerullo M, Koljonen L, Holmlund-Suila E, Hauta-Alus H, Rosendahl J, Valkama S . Genetic Variation of the Vitamin D Binding Protein Affects Vitamin D Status and Response to Supplementation in Infants. J Clin Endocrinol Metab. 2019; 104(11):5483-5498. DOI: 10.1210/jc.2019-00630. View

Moy K, Mondul A, Zhang H, Weinstein S, Wheeler W, Chung C . Genome-wide association study of circulating vitamin D-binding protein. Am J Clin Nutr. 2014; 99(6):1424-31. PMC: 4021784. DOI: 10.3945/ajcn.113.080309. View

Lauridsen A, Vestergaard P, Hermann A, Brot C, Heickendorff L, Mosekilde L . Plasma concentrations of 25-hydroxy-vitamin D and 1,25-dihydroxy-vitamin D are related to the phenotype of Gc (vitamin D-binding protein): a cross-sectional study on 595 early postmenopausal women. Calcif Tissue Int. 2005; 77(1):15-22. DOI: 10.1007/s00223-004-0227-5. View

Safadi F, Thornton P, Magiera H, Hollis B, Gentile M, Haddad J . Osteopathy and resistance to vitamin D toxicity in mice null for vitamin D binding protein. J Clin Invest. 1999; 103(2):239-51. PMC: 407885. DOI: 10.1172/JCI5244. View

Bikle D, Gee E, Halloran B, Kowalski M, Ryzen E, Haddad J . Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D-binding protein. J Clin Endocrinol Metab. 1986; 63(4):954-9. DOI: 10.1210/jcem-63-4-954. View

Jones K, Assar S, Harnpanich D, Bouillon R, Lambrechts D, Prentice A . 25(OH)D2 half-life is shorter than 25(OH)D3 half-life and is influenced by DBP concentration and genotype. J Clin Endocrinol Metab. 2014; 99(9):3373-81. PMC: 4207933. DOI: 10.1210/jc.2014-1714. View

Jenkinson C, Desai R, McLeod M, Mueller J, Hewison M, Handelsman D . Circulating Conjugated and Unconjugated Vitamin D Metabolite Measurements by Liquid Chromatography Mass Spectrometry. J Clin Endocrinol Metab. 2021; 107(2):435-449. PMC: 9211013. DOI: 10.1210/clinem/dgab708. View

Best C, Sherwood R, Novotny J, Zhang S, Pressman E, OBrien K . Vitamin D kinetics in nonpregnant and pregnant women after a single oral dose of trideuterated vitamin D. J Steroid Biochem Mol Biol. 2021; 216:106034. PMC: 8749867. DOI: 10.1016/j.jsbmb.2021.106034. View

Hsu S, Zelnick L, Lin Y, Best C, Kestenbaum B, Thummel K . Differences in 25-Hydroxyvitamin D Clearance by eGFR and Race: A Pharmacokinetic Study. J Am Soc Nephrol. 2020; 32(1):188-198. PMC: 7894669. DOI: 10.1681/ASN.2020050625. View

10.

Brouwer D, van Beek J, Ferwerda H, Brugman A, van der Klis F, van der Heiden H . Rat adipose tissue rapidly accumulates and slowly releases an orally-administered high vitamin D dose. Br J Nutr. 1998; 79(6):527-32. DOI: 10.1079/bjn19980091. View

11.

Depreter B, Heijboer A, Langlois M . Accuracy of three automated 25-hydroxyvitamin D assays in hemodialysis patients. Clin Chim Acta. 2012; 415:255-60. DOI: 10.1016/j.cca.2012.10.056. View

12.

Bikle D, Schwartz J . Vitamin D Binding Protein, Total and Free Vitamin D Levels in Different Physiological and Pathophysiological Conditions. Front Endocrinol (Lausanne). 2019; 10:317. PMC: 6546814. DOI: 10.3389/fendo.2019.00317. View

13.

Henderson C, Lutsey P, Misialek J, Laha T, Selvin E, Eckfeldt J . Measurement by a Novel LC-MS/MS Methodology Reveals Similar Serum Concentrations of Vitamin D-Binding Protein in Blacks and Whites. Clin Chem. 2015; 62(1):179-87. PMC: 4698095. DOI: 10.1373/clinchem.2015.244541. View

14.

Bouillon R, Schuit F, Antonio L, Rastinejad F . Vitamin D Binding Protein: A Historic Overview. Front Endocrinol (Lausanne). 2020; 10:910. PMC: 6965021. DOI: 10.3389/fendo.2019.00910. View

15.

Hong J, Hatchell K, Bradfield J, Bjonnes A, Chesi A, Lai C . Transethnic Evaluation Identifies Low-Frequency Loci Associated With 25-Hydroxyvitamin D Concentrations. J Clin Endocrinol Metab. 2018; 103(4):1380-1392. PMC: 6276579. DOI: 10.1210/jc.2017-01802. View

16.

Sato K, Gray R, LEMANN Jr J . Urinary excretion of 25-hydroxyvitamin D in health and the nephrotic syndrome. J Lab Clin Med. 1982; 99(3):325-30. View

17.

Benet L, Zia-Amirhosseini P . Basic principles of pharmacokinetics. Toxicol Pathol. 1995; 23(2):115-23. DOI: 10.1177/019262339502300203. View

18.

Wang T, Zhang F, Richards J, Kestenbaum B, van Meurs J, Berry D . Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet. 2010; 376(9736):180-8. PMC: 3086761. DOI: 10.1016/S0140-6736(10)60588-0. View

19.

Arnaud J, Constans J . Affinity differences for vitamin D metabolites associated with the genetic isoforms of the human serum carrier protein (DBP). Hum Genet. 1993; 92(2):183-8. DOI: 10.1007/BF00219689. View

20.

Duconge J . Applying organ clearance concepts in a clinical setting. Am J Pharm Educ. 2009; 72(5):121. PMC: 2630146. DOI: 10.5688/aj7205121. View